Please provide your email address to receive an email when new articles are posted on . Azole-resistant Aspergillus fumigatus has become an increasing problem worldwide over the last decade.

How could improvement in the management of T-cell acute lymphoblastic leukemia be achieved? Experience of Princess Nourah Oncology Center, National Guard Hospital, Jeddah, Saudi Arabia No significant ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. On Tuesday, June 1 st, the Food and Drug Administration on Tuesday ...

A new study suggests that adding common bone loss drugs to azoles can improve efficacy when treating fungal infections. Human skin, hair and nails are all vulnerable to fungal infections. While these ...

Aspergillus fumigatus is a ubiquitous mould that poses significant health risks, particularly in immunocompromised individuals, through invasive pulmonary aspergillosis. Over recent decades, the ...

Kumaraguru Raja, Ph.D., MBA, is Vice President, Biotechnology Research at Noble Life Science Partners. Dr. Raja has significant experience as an Equity Analyst in the health care industry with a focus ...

Pharmaceutical firms are making progress in addressing the need for new antifungal therapies. F2G says olorofim is part of the first new class of antifungals to be developed in 20 years. F2G’s chief ...

Expert Rev Anti Infect Ther. 2011;9(3):283-284. Pediatric patients are not simply 'little adults'. This mantra can be echoed throughout the entire discipline of pediatric medicine, where differences ...